Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
BROOMFIELD, CO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it will be presenting at the upcoming Virtual Investor Summit on August 20 th , 2024. Investors may request a one-on-one meeting with management by registering here: .
2024年8月15日科罗拉多州布鲁姆菲尔德(GLOBE NEWSWIRE)——医疗保健科技公司Aclarion,Inc.(“Aclarion”或“公司”)(纳斯达克:ACON,ACONW)利用生物标志物和专有的增强智能算法帮助医生确定慢性下腰痛的位置。(在2024年8月20日即将举行的虚拟投资者峰会上,宣布将进行演示。投资者可以通过在此处注册来请求与管理层的一对一会议。) .
Event: Q3 Investor Summit
Date: August 20, 2024
Presentation Time: 4:00 PM ET
Location:
活动:Q3投资者峰会
日期:2024年8月20日
演示时间:美国东部时间下午4:00
地点:
About Aclarion, Inc.
关于Aclarion, Inc.
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit .
Aclarion是一家医疗保健科技公司,利用磁共振光谱(“MRS”),专有的信号处理技术,生物标志物和增强智能算法来优化临床治疗。该公司首先通过Nociscan解决慢性下腰痛市场,Nociscan是第一个有证据支持的SaaS平台,可非侵入性地帮助医生区分腰椎椎间盘疼痛和非疼痛性椎间盘。通过云连接,Nociscan从每个评估的腰部椎间盘的MRI机器中接收磁共振光谱(MRS)数据。在云中,专有的信号处理技术提取和量化与盘痛相关的化学生物标志物。将生物标志物数据输入专有算法中,以指示盘可能是疼痛源。当与其他诊断工具一起使用时,Nociscan为医生提供有关患者下背痛位置的关键洞察力,使医生可以优化治疗策略。欲了解更多信息,请访问: .
Investor Contacts:
Kirin M. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com
投资者联系人:查看更多信息前往:
Kirin m. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com
Media Contacts:
Jodi Lamberti
SPRIG Consulting
612.812.7477
jodi@sprigconsulting.com
媒体联系人:
Jodi Lamberti
SPRIG咨询公司
612.812.7477
jodi@sprigconsulting.com